Literature DB >> 20842104

Paracrine factors of multipotent stromal cells ameliorate lung injury in an elastase-induced emphysema model.

Ahmed M Katsha1, Shinya Ohkouchi, Hong Xin, Masahiko Kanehira, Ruowen Sun, Toshihiro Nukiwa, Yasuo Saijo.   

Abstract

Multipotent stromal cells (MSCs) ameliorate several types of lung injury. The differentiation of MSCs into specific cells at the injury site has been considered as the important process in the MSC effect. However, although MSCs reduce destruction in an elastase-induced lung emphysema model, MSC differentiation is relatively rare, suggesting that MSC differentiation into specific cells does not adequately explain the recuperation observed. Humoral factors secreted by MSCs may also play an important role in ameliorating emphysema. To confirm this hypothesis, emphysema was induced in the lungs of C57BL/6 mice by intratracheal elastase injection 14 days before intratracheal MSC or phosphate-buffered saline (PBS) administration. Thereafter, lungs were collected at several time points and evaluated. Our results showed that MSCs reduced the destruction in elastase-induced emphysema. Furthermore, double immunofluorescence staining revealed infrequent MSC engraftment and differentiation into epithelial cells. Real-time PCR showed increased levels of hepatocyte growth factor (HGF) and epidermal growth factor (EGF). Real-time PCR and western blotting showed enhanced production of secretory leukocyte protease inhibitor (SLPI) in the lung. In-vitro coculture studies confirmed the in vivo observations. Our findings suggest that paracrine factors derived from MSCs is the main mechanism for the protection of lung tissues from elastase injury.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20842104      PMCID: PMC3017437          DOI: 10.1038/mt.2010.192

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  49 in total

1.  IL-1R1/MyD88 signaling is critical for elastase-induced lung inflammation and emphysema.

Authors:  Isabelle Couillin; Virginie Vasseur; Sabine Charron; Pamela Gasse; Marie Tavernier; Julien Guillet; Vincent Lagente; Lizette Fick; Muazzam Jacobs; Fernando Rodrigues Coelho; René Moser; Bernhard Ryffel
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

2.  Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung.

Authors:  Jae W Lee; Xiaohui Fang; Naveen Gupta; Vladimir Serikov; Michael A Matthay
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-31       Impact factor: 11.205

Review 3.  Marrow stromal cells as stem cells for nonhematopoietic tissues.

Authors:  D J Prockop
Journal:  Science       Date:  1997-04-04       Impact factor: 47.728

4.  Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats.

Authors:  G D Massaro; D Massaro
Journal:  Nat Med       Date:  1997-06       Impact factor: 53.440

5.  Destructive index: a measurement of lung parenchymal destruction in smokers.

Authors:  M Saetta; R J Shiner; G E Angus; W D Kim; N S Wang; M King; H Ghezzo; M G Cosio
Journal:  Am Rev Respir Dis       Date:  1985-05

Review 6.  Secretory leukoprotease inhibitor: partnering alpha 1-proteinase inhibitor to combat pulmonary inflammation.

Authors:  L Bingle; T D Tetley
Journal:  Thorax       Date:  1996-12       Impact factor: 9.139

7.  Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease.

Authors:  Muhammad Aslam; Rajiv Baveja; Olin D Liang; Angeles Fernandez-Gonzalez; Changjin Lee; S Alex Mitsialis; Stella Kourembanas
Journal:  Am J Respir Crit Care Med       Date:  2009-08-27       Impact factor: 21.405

8.  Mesenchymal stem cell-based angiopoietin-1 gene therapy for acute lung injury induced by lipopolysaccharide in mice.

Authors:  J Xu; J Qu; L Cao; Y Sai; C Chen; L He; L Yu
Journal:  J Pathol       Date:  2008-03       Impact factor: 7.996

9.  Human umbilical cord blood-derived mesenchymal stem cells attenuate hyperoxia-induced lung injury in neonatal rats.

Authors:  Yun Sil Chang; Wonil Oh; Soo Jin Choi; Dong Kyung Sung; Soo Yoon Kim; Eun Yang Choi; Saem Kang; Hye Jin Jin; Yoon Sun Yang; Won Soon Park
Journal:  Cell Transplant       Date:  2009-04-09       Impact factor: 4.064

10.  Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force.

Authors:  N M Siafakas; P Vermeire; N B Pride; P Paoletti; J Gibson; P Howard; J C Yernault; M Decramer; T Higenbottam; D S Postma
Journal:  Eur Respir J       Date:  1995-08       Impact factor: 16.671

View more
  87 in total

Review 1.  Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012.

Authors:  Daniel J Weiss
Journal:  Ann Am Thorac Soc       Date:  2013-10

2.  Stem cells and cell therapies in lung biology and diseases: conference report.

Authors:  Daniel J Weiss; Jason H T Bates; Thomas Gilbert; W Conrad Liles; Carolyn Lutzko; Jay Rajagopal; Darwin Prockop
Journal:  Ann Am Thorac Soc       Date:  2013-10

3.  Therapeutic Treatment with Abdominal Adipose Mesenchymal Cells Does Not Prevent Elastase-Induced Emphysema in Rats.

Authors:  Pınar Yıldız Gülhan; Mehmet Savaş Ekici; Mehmet Niyaz; Muhammet Gülhan; Mustafa Emre Erçin; Aydanur Ekici; Nurkan Aksoy
Journal:  Turk Thorac J       Date:  2020-01-01

4.  Stem cells and cell therapies in lung biology and lung diseases.

Authors:  Daniel J Weiss; Ivan Bertoncello; Zea Borok; Carla Kim; Angela Panoskaltsis-Mortari; Susan Reynolds; Mauricio Rojas; Barry Stripp; David Warburton; Darwin J Prockop
Journal:  Proc Am Thorac Soc       Date:  2011-06

Review 5.  In vitro augmentation of mesenchymal stem cells viability in stressful microenvironments : In vitro augmentation of mesenchymal stem cells viability.

Authors:  Fatemeh Amiri; Ali Jahanian-Najafabadi; Mehryar Habibi Roudkenar
Journal:  Cell Stress Chaperones       Date:  2014-12-20       Impact factor: 3.667

6.  Growth factors enhance liver regeneration in acute-on-chronic liver failure.

Authors:  Chandan Kumar Kedarisetty; Lovkesh Anand; Arshi Khanam; Anupam Kumar; Archana Rastogi; Rakhi Maiwall; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2014-05-25       Impact factor: 6.047

Review 7.  Stem cell recruitment after injury: lessons for regenerative medicine.

Authors:  Robert C Rennert; Michael Sorkin; Ravi K Garg; Geoffrey C Gurtner
Journal:  Regen Med       Date:  2012-11       Impact factor: 3.806

8.  Cell therapy with bone marrow mononuclear cells in elastase-induced pulmonary emphysema.

Authors:  Nathalia Longhini-Dos-Santos; Valter Abraão Barbosa-de-Oliveira; Rodrigo Heras Kozma; Carolina Arruda de Faria; Talita Stessuk; Fernando Frei; João Tadeu Ribeiro-Paes
Journal:  Stem Cell Rev Rep       Date:  2013-04       Impact factor: 5.739

Review 9.  Regenerative pulmonary medicine: potential and promise, pitfalls and challenges.

Authors:  Piero Anversa; Mark A Perrella; Stella Kourembanas; Augustine M K Choi; Joseph Loscalzo
Journal:  Eur J Clin Invest       Date:  2012-03-21       Impact factor: 4.686

Review 10.  Experimental basis and new insights for cell therapy in Chronic Obstructive Pulmonary Disease.

Authors:  Carolina Arruda de Faria; Rodrigo de las Heras Kozma; Talita Stessuk; João Tadeu Ribeiro-Paes
Journal:  Stem Cell Rev Rep       Date:  2012-12       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.